Citations (0)
Keep up to date with the latest research on this topic with citation updates for this article.
Pharmacogenomics and Personalized Medicine
Volume 16, 2023 - Issue
CASE REPORT
Massive Hepatocellular Carcinoma with Situs Inversus Totalis Achieved a Complete Response Following Camrelizumab Plus Apatinib and Combined with Two-Stage Hepatectomy: A Case Report
, 
, , , , , , , & show all
Shenjian Ou1 Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, 530021, People’s Republic of Chinahttps://orcid.org/0000-0002-0296-8758View further author information
https://orcid.org/0000-0002-0296-8758View further author information, Xiwen Liao1 Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, 530021, People’s Republic of China;2 Guangxi Key Laboratory of Enhanced Recovery After Surgery for Gastrointestinal Cancer, Nanning, Guangxi Zhuang Autonomous Region, 530021, People’s Republic of Chinahttps://orcid.org/0000-0002-1724-1463View further author information
https://orcid.org/0000-0002-1724-1463View further author information, , Chengkun Yang1 Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, 530021, People’s Republic of China;2 Guangxi Key Laboratory of Enhanced Recovery After Surgery for Gastrointestinal Cancer, Nanning, Guangxi Zhuang Autonomous Region, 530021, People’s Republic of Chinahttps://orcid.org/0000-0001-6109-7334View further author information
https://orcid.org/0000-0001-6109-7334View further author information, , Yufeng Tan1 Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, 530021, People’s Republic of Chinahttps://orcid.org/0000-0001-6362-0002View further author information
https://orcid.org/0000-0001-6362-0002View further author information, , Tao Peng1 Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, 530021, People’s Republic of China;2 Guangxi Key Laboratory of Enhanced Recovery After Surgery for Gastrointestinal Cancer, Nanning, Guangxi Zhuang Autonomous Region, 530021, People’s Republic of Chinahttps://orcid.org/0000-0001-6133-7078View further author information
https://orcid.org/0000-0001-6133-7078View further author information & Xinping Ye1 Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, 530021, People’s Republic of ChinaCorrespondence[email protected] [email protected]
https://orcid.org/0000-0003-2990-9333View further author information
https://orcid.org/0000-0003-2990-9333View further author information show all